FDA inspection
Dexcowin Co. Ltd.: FDA inspection ending Feb 23, 2023
FDA inspection 1198194 · Voluntary Action Indicated (VAI) · Geumcheon
Key facts
| Inspection ID | 1198194 |
|---|---|
| Firm | Dexcowin Co. Ltd. |
| FEI number | 3007065358 |
| Address | 901~905 25 Gasan Digital 1-Ro |
| City | Geumcheon |
| Country | Korea (the Republic of) |
| Fiscal year | 2023 |
| Inspection end date | Feb 23, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data